ATM and T-cell non-Hodgkin lymphoma: In the present study, we report encouraging preclinical data describing the benefits of ATM inhibition in promoting CHOEP-induced cell death in preclinical models of T-cell lymphoma using two different chemical compounds—AZD0156 and KU-55933.